Enhancement of T-cell–Mediated Antitumor Response: Angiostatic Adjuvant to Immunotherapy against Cancer

R.P. Dings, K.B. Vang, K. Castermans, F. Popescu, Y. Zhang, M.G. oude Egbrink, M.F. Mescher, M.A. Farrar, A.W. Griffioen, K.H. Mayo

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)3134-3145
JournalClinical Cancer Research
Volume17
Issue number10
DOIs
Publication statusPublished - 2011

Cite this

Dings, R. P., Vang, K. B., Castermans, K., Popescu, F., Zhang, Y., oude Egbrink, M. G., ... Mayo, K. H. (2011). Enhancement of T-cell–Mediated Antitumor Response: Angiostatic Adjuvant to Immunotherapy against Cancer. Clinical Cancer Research, 17(10), 3134-3145. https://doi.org/10.1158/1078-0432.CCR-10-2443